
You can purchase shares of Veraxa Biotech Holding (NASDAQ:VRXAW) through any online brokerage.
There are no as such competitors for Veraxa Biotech Holding.
There is no analysis for Veraxa Biotech Holding to provide a consensus price target.
The stock price for Veraxa Biotech Holding (NASDAQ: VRXAW) is $0.0301 last updated October 30, 2026 at 8:29 AM EDT.
There are no upcoming dividends for Veraxa Biotech Holding.
Veraxa Biotech Holding does not have any upcoming earnings scheduled.
There is no upcoming split for Veraxa Biotech Holding.
Veraxa Biotech Holding is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new...